Local Institution - 112 — Chicago, Illinois

Local Institution - 112 is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 112 has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 112?

Local Institution - 112 has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 112 conducted?

Local Institution - 112 has 3 clinical trials on record, with 2 currently active. Their work covers Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis.

Is Local Institution - 112 accredited by Crixeo Health?

Local Institution - 112 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 112?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.